γCD/HPγCD: Synergistic solubilization

International Journal of Pharmaceutics

Volumn 363, Issue 1-2, 2008, Pages 217-219

  Jansook, Phatsawee ^a   Loftsson, Thorsteinn ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Cyclodextrin; Solubilization; Steroids; Synergistic effect

Indexed keywords

2 HYDROXYPROPYL GAMMA CYCLODEXTRIN; DEXAMETHASONE; GAMMA CYCLODEXTRIN; GAMMA CYCLODEXTRIN DERIVATIVE; HYDROCORTISONE; SOLUBILIZER; UNCLASSIFIED DRUG; HYDROXYPROPYL GAMMA CYCLODEXTRIN; HYDROXYPROPYL-GAMMA-CYCLODEXTRIN;

ARTICLE; COMPLEX FORMATION; DRUG POTENTIATION; DRUG SOLUBILITY; PRIORITY JOURNAL; SOLUBILIZATION; TURBIDITY; CHEMICAL MODEL; CHEMISTRY; PHOTOMETRY; SOLUBILITY;

CHEMISTRY, PHARMACEUTICAL; DEXAMETHASONE; GAMMA-CYCLODEXTRINS; HYDROCORTISONE; MODELS, CHEMICAL; NEPHELOMETRY AND TURBIDIMETRY; SOLUBILITY;

EID: 51649088096     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.07.011     Document Type: Article

References (7)

1. Brewster M.E., and Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59 (2007) 645-666
2. Connors K.A. Population characteristics of cyclodextrin complex stabilities in aqueous solution. J. Pharm. Sci. 84 (1995) 843-848
3. Higuchi T., and Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4 (1965) 117-212
4. Koutsou G.A., Storey D.M., and Bär A. Gastrointestinal tolerance of γ-cyclodextrin in humans. Food Addit. Contam. 16 (1999) 313-317
5. Loftsson T., Hreinsdóttir D., and Másson M. Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302 (2005) 18-28
6. Munro I.C., Newberne P.M., Young R.R., and Bär A. Safety assessment of γ-cyclodextrin. Regul. Toxicol. Pharmacol. 39 Suppl. 1 (2004) S3-S13
7. Szente L., Szejtli J., and Kis G.L. Spontaneous opalescence of aqueous γ-cyclodextrin solutions: complex formation or self-aggregation. J. Pharm. Sci. 87 (1998) 778-781